ACELYRIN Inc.

ACELYRIN Inc.

World Rank (Jan-05-2024)
10,200
Market Cap (Jan-05-2024)
0.744 Billion USD
World Rank (Jul-30-2023)
8,797
Market Cap (Jul-30-2023)
0.989 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
SLRN
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
ACELYRIN INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
ACELYRIN is a biopharma company that builds therapies and actively investigating the potential of izokibep and other programs in diseases where differentiated therapeutic approaches are required to address unmet patient needs. Headquarters is in USA.
IPO Year
2023
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share